<DOC>
	<DOCNO>NCT00935961</DOCNO>
	<brief_summary>The purpose study test safety RAD001 ( everolimus ) tablets different dose level , add docetaxel cisplatin . The investigator want find effect , good and/or bad , everolimus add docetaxel cisplatin treatment head neck cancer .</brief_summary>
	<brief_title>RAD001 ( Everolimus ) + Docetaxel + Cisplatin Induction Chemotherapy Patients With Local-Regional Advanced Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Stage IIIIVB head neck squamous cell carcinoma ( HNSCC ) nasopharyngeal cancer ( WHO type I , II III ) , , previously untreated . Patients stage II hypopharynx HNSCC also eligible . Pathology must confirm MSKCC Age ≥ 18 year Karnofsky performance status ≥ 70 % Adequate bone marrow function : Absolute neutrophil count ≥ 1.5 X 109/L , Platelets ≥ 100 x 109/L , Hemoglobin &gt; 10 g/dL . Adequate liver function Serum bilirubin must within upper limit normal . ( ULN ) . AST ALT Alkaline Phosphatase must within range allow eligibility Adequate renal function : serum creatinine within institutional normal limit , calculate creatinine clearance ( Cockcroft Gault method ) ≥ 55 mL/min patient creatinine limit institutional normal INR &lt; 1.5 aPTT &lt; 1.5 X upper limit normal Negative urine serum pregnancy test within 14 day prior administration RAD001 Men woman childbearing potential must willing consent use effective contraception treatment least 3 month thereafter . Patients must ability understand willingness sign write informed consent document Any prior treatment RAD001 , agent specifically target mTOR Any prior radiation therapy head neck cancer . Any prior radiation therapy &gt; 25 % bone marrow . Any prior radiation whole pelvis and/or brain Therapeutic anticoagulation coumadin ( warfarin ) Hypertriglyceridemia ≥ grade 2 ( CTCAE version 3.0 ) Patients require chronic treatment steroid ( &gt; prednisone 5 mg/day ) immunosuppressive agent exclude . Both cisplatin RAD001 immunosuppressive , chronic steroid use ( &gt; prednisone 5 mg/day ) use immunosuppressive agent might increase risk lethal infection set . Patients low dose steroid replacement regimen ( ≤ prednisone 5 mg/day ) exclude , low dose steroid immunosuppressive Impairment gastrointestinal function gastrointestinal disease may significantly alter absorption RAD001 ( e.g. , ulcerative disease , uncontrolled nausea , vomit , diarrhea , malabsorption syndrome small bowel resection ) Active infection serious underlie medical condition would impair patient 's ability receive protocol treatment . Other concurrent severe and/or uncontrolled medical disease would compromise participation study opinion investigator ( e.g. , uncontrolled diabetes , unstable angina , congestive heart failure New York Heart Association Class III IV ) HIVpositive patient . These patient increase risk lethal infection treat marrow suppressive therapy . Additionally , pharmacokinetic interaction antiretroviral therapy study regimen may problematic patient Women pregnant lactate Other active malignancy , indolent malignancy investigator determines unlikely interfere treatment safety analysis . For example , patient nonmelanoma skin cancer , situ carcinoma cervix , prostate cancer current biochemical ( PSA ) radiologic evidence disease may enroll Patients hear loss require hear aid intervention ( i.e . interfere clinical significant way activity daily live ) . Patients multifocal peripheral sensory alteration paresthesias ( include tingle ) interfere function , per patient report ( example : activity daily live ) Impaired lung function : O2 saturation 88 % less rest room air Pulse Oximetry . If O2 saturation ≤ 88 % rest , pulmonary function test ( PFTs ) order confirm normal pulmonary function eligibility Patients receive immunization attenuate live vaccine within one week study entry study period . Close contact receive attenuated live vaccine avoid treatment everolimus . Examples live vaccine include intranasal influenza , measles , mumps , rubella , oral polio , BCG , yellow fever , varicella , TY21a typhoid vaccine Liver disease cirrhosis severe hepatic impairment ( ChildsPugh class C )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>CISPLATIN</keyword>
	<keyword>RAD001</keyword>
	<keyword>TAXOTERE ( DOCETAXEL )</keyword>
	<keyword>09-028</keyword>
	<keyword>Squamous Cell Carcinoma</keyword>
	<keyword>Local-Regional Advanced Head Neck</keyword>
</DOC>